Barriers to Prescribing Crizotinib Following FDA Approval - a podcast by American Society of Clinical Oncology (ASCO)

from 2012-07-10T04:23:45

:: ::

by Robert S. Miller, MD. Dr. Nathan Pennell discusses some of the interesting obstacles he encountered when trying to prescribe crizotinib for 3 patients with ALK positive non-small cell lung cancer in the first few weeks following FDA approval in 2011.